Roche Holding AG (ETR:RHO)

Market Cap	230.15B
Revenue (ttm)	66.51B
Net Income (ttm)	8.82B
Shares Out	n/a
EPS (ttm)	10.99
PE Ratio	26.09
Forward PE	13.36
Dividend	9.70 (3.14%)
Ex-Dividend Date	Mar 27, 2025

Volume	91
Average Volume	2,354
Open	308.40
Previous Close	306.00
Day's Range	306.00 - 308.60
52-Week Range	282.00 - 314.00
Beta	n/a
RSI	51.11
Earnings Date	Jul 24, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1896
• Employees: 103,249
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: RHO

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF